Table 4.
Effects | MBM | Phy | AB | RBC (109/mL)12.5–3.5 | Hgb (g/dl)17–13 | PCV (%)122–52 | MCV (fL)1 90–140 | MCH (pg)133–47 | MCHC (g/dL)126–35 | Platelets (106/mL) |
---|---|---|---|---|---|---|---|---|---|---|
Treatment means | ||||||||||
1. | − | 500 | − | 2.01 | 10.9 | 21.5 | 107.1 | 54.4 | 50.8 | 0.74b,c |
2. | − | 1,500 | − | 2.25 | 12.3 | 24.6 | 109.5 | 54.8 | 50.0 | 2.72a,b |
3. | − | 500 | + | 2.08 | 11.2 | 22.5 | 108.2 | 53.9 | 49.8 | 3.25a |
4. | − | 1,500 | + | 2.29 | 12.6 | 24.6 | 107.6 | 55.1 | 51.2 | 1.19a,b,c |
5. | + | 500 | − | 2.01 | 11.1 | 21.5 | 107.2 | 57.2 | 53.4 | 1.43a,b,c |
6. | + | 1,500 | − | 2.15 | 11.9 | 23.2 | 107.7 | 55.5 | 51.5 | 0.62c |
7. | + | 500 | + | 2.15 | 11.7 | 23.0 | 107.1 | 54.3 | 50.8 | 0.95b,c |
8. | + | 1,500 | + | 2.15 | 11.8 | 23.3 | 108.3 | 54.6 | 50.4 | 1.09b,c |
Main effects | ||||||||||
AB | − | 2.06b | 11.2b | 22.12b | 107.4 | 54.9 | 51.2 | 1.60 | ||
+ | 2.21a | 12.2b | 23.90a | 108.3 | 54.9 | 50.8 | 1.40 | |||
P > f | ||||||||||
MBM | 0.548 | 0.702 | 0.441 | 0.392 | 0.350 | 0.214 | 0.006 | |||
Phy | 0.317 | 0.465 | 0.336 | 0.894 | 0.290 | 0.311 | 0.468 | |||
AB | 0.027 | 0.010 | 0.014 | 0.182 | 0.963 | 0.650 | 0.564 | |||
MBM × Phy | 0.901 | 0.867 | 0.835 | 0.616 | 0.327 | 0.254 | 0.458 | |||
MBM × AB | 0.257 | 0.178 | 0.245 | 0.955 | 0.400 | 0.397 | 0.654 | |||
Phy × AB | 0.516 | 0.575 | 0.398 | 0.368 | 0.455 | 0.281 | 0.025 | |||
MBM × Phy × AB | 0.676 | 0.573 | 0.902 | 0.147 | 0.754 | 0.855 | 0.001 |
a,b,c Means in the same column within the main effect, 2-way interaction, or treatment means with different superscripts are different (P < 0.05).
2- or 3-way interaction separated by Tukey.
Abbreviations: AB, salinomycin 60 ppm in S, G, F; Zn bacitracin 100 ppm in S, G and 50 ppm in F; Hgb, hemoglobin; MBM, meat and bone meal; MCH, mean corpuscular hemoglobin and MCHC, mean corpuscular hemoglobin concentration; MCV, mean corpuscular volume; PCV, packed cell volume; Phy, phytase (Quantum Blue 5G); RBC, red blood cells.